↓ Skip to main content

Dove Medical Press

Can Antidiabetic Medications Affect Telomere Length in Patients with Type 2 Diabetes? A Mini-Review

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, November 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter
5 X users

Readers on

mendeley
12 Mendeley
Title
Can Antidiabetic Medications Affect Telomere Length in Patients with Type 2 Diabetes? A Mini-Review
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, November 2023
DOI 10.2147/dmso.s428560
Pubmed ID
Authors

Baoding Qin

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 12 100%

Demographic breakdown

Readers by professional status Count As %
Lecturer 2 17%
Lecturer > Senior Lecturer 1 8%
Student > Doctoral Student 1 8%
Student > Master 1 8%
Professor > Associate Professor 1 8%
Other 0 0%
Unknown 6 50%
Readers by discipline Count As %
Medicine and Dentistry 2 17%
Nursing and Health Professions 1 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 8%
Immunology and Microbiology 1 8%
Psychology 1 8%
Other 0 0%
Unknown 6 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 December 2023.
All research outputs
#16,067,611
of 26,180,352 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#486
of 1,207 outputs
Outputs of similar age
#165,359
of 371,423 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#6
of 32 outputs
Altmetric has tracked 26,180,352 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,207 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.2. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 371,423 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.